Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Barnett

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
British Journal of Clinical Pharmacology|August 19, 2010
Pharmacoeconomics: NICE's approach to decision-makingMichael Rawlins, David Barnett, Andrew Stevens
The Lancet. Oncology|April 12, 2003
The cancer technology appraisal programme of the UK's National Institute for Clinical ExcellencePeter Littlejohns, David Barnett, Carole Longson, et al.
Lancet (London, England)|July 13, 2004
Assessment of NICE guidancePeter Littlejohns, Andrew Dillon, David Barnett
Proceedings (Baylor University. Medical Center)|January 26, 2007
Unusual presentation of myelopathy in a previously healthy manDaniel A Marichal, Joseph Hise, David Barnett
Journal of Deaf Studies and Deaf Education|July 2, 2010
How are they really doing? Observation of inclusionary classroom participation for children with mild-to-moderate deafnessChristina M Borders, David Barnett, Anne M Bauer
Cytometry. Part B, Clinical Cytometry|July 24, 2015
Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myelomaTeri A Oldaker, Paul K Wallace, David Barnett
The Lancet. Oncology|November 6, 2009
Pemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisalPanagiota Vrouchou, Prashanth Kandaswamy, Elisabeth George, et al.
Cytometry. Part B, Clinical Cytometry|March 3, 2016
Current international flow cytometric practices for the detection and monitoring of paroxysmal nocturnal haemoglobinuria clones: A UK NEQAS surveyMatthew Fletcher, Liam Whitby, Alison Whitby, et al.
Nature Reviews. Microbiology|October 25, 2008
CD4 immunophenotyping in HIV infectionDavid Barnett, Brooke Walker, Alan Landay, et al.
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part I - rationale and aimsBruce H Davis, Brent Wood, Teri Oldaker, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
British Journal of Clinical Pharmacology|August 19, 2010
Pharmacoeconomics: NICE's approach to decision-makingMichael Rawlins, David Barnett, Andrew Stevens
The Lancet. Oncology|April 12, 2003
The cancer technology appraisal programme of the UK's National Institute for Clinical ExcellencePeter Littlejohns, David Barnett, Carole Longson, et al.
Lancet (London, England)|July 13, 2004
Assessment of NICE guidancePeter Littlejohns, Andrew Dillon, David Barnett
Proceedings (Baylor University. Medical Center)|January 26, 2007
Unusual presentation of myelopathy in a previously healthy manDaniel A Marichal, Joseph Hise, David Barnett
Journal of Deaf Studies and Deaf Education|July 2, 2010
How are they really doing? Observation of inclusionary classroom participation for children with mild-to-moderate deafnessChristina M Borders, David Barnett, Anne M Bauer
Cytometry. Part B, Clinical Cytometry|July 24, 2015
Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myelomaTeri A Oldaker, Paul K Wallace, David Barnett
The Lancet. Oncology|November 6, 2009
Pemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisalPanagiota Vrouchou, Prashanth Kandaswamy, Elisabeth George, et al.
Cytometry. Part B, Clinical Cytometry|March 3, 2016
Current international flow cytometric practices for the detection and monitoring of paroxysmal nocturnal haemoglobinuria clones: A UK NEQAS surveyMatthew Fletcher, Liam Whitby, Alison Whitby, et al.
Nature Reviews. Microbiology|October 25, 2008
CD4 immunophenotyping in HIV infectionDavid Barnett, Brooke Walker, Alan Landay, et al.
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part I - rationale and aimsBruce H Davis, Brent Wood, Teri Oldaker, et al.
Pageof 8